When Antibodies Become the Drug Factory

Abstract

Get full access to this article

View all access options for this article.

References

Yip

C.W.

Nguyen

Le Rouzic

, et al. Retargeting of AAV using bispecific antibodies. Molecular Therapy. 32(S1):Abstract 218. (2024).

Hadaya

Nguyen

Keating

, et al. Retargeting of AAV to CNS using antiAAV × TFR1 bispecific antibodies. Molecular Therapy. 33(S1):Abstract 542. (2025).

Nabih

N.W.

Hassan

H.A.F.M

Preis

, et al. Antibody-functionalized lipid nanocarriers for RNA-based cancer gene therapy: advances and challenges in targeted delivery. Nanoscale Advances. 19:5905–5931. (2025).